 |
 |
Browse all recently published reports
May 20, 2008
Novel Glycopeptides and Cephalosporins Will Drive the Hospital-Acquired Infections Drug Market Through 2017... more>>
May 19, 2008
Increased Competition, Generic Erosion and Cost Consciousness Will Cause the Asthma Drug Market to Decline to $10.1 Billion in 2017... more>>
May 15, 2008
Daiichi Sankyo/Eli Lilly's Effient and Astrazeneca's Ticagrelor May Offer Advantages in the Treatment of Post-Myocardial Infarction... more>>
View all press releases
|
|
|
 |
|
|
Atypical Antipsychotics Report
Listen to an interview with analyst Sandra Chow in which she discusses the atypical antipsychotics drug market.
Ms. Chow is the author of the Brands & Strategies: Atypical Antipsychotics report. In this interview, Ms. Chow discusses the shifts in market leadership that will continue to characterize the atypical antipsychotics drug market as leading therapies face increasing generic competition.
Listen to Interview
|
|
 |
 |
|
Opportunities for Emerging Disease-Modifying Therapies in Multiple Sclerosis
Based on our recent Treatment Algorithms in Multiple Sclerosis report, Decision Resources is offering this in-depth webinar on June 11, 2008.
Click here to learn more.
|
|
